Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00280280 · ClinicalTrials.gov registry record · Phase 1
Botox vs. Baclofen for Upper Limb Spasticity
A Phase 1 study, sponsored by Vanderbilt University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT00280280 is a Phase 1 study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 8 participants.
The verdict
NCT00280280, a Phase 1 study, was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purposes of this pilot study are to evaluate the safety and efficacy of Botox® compared to the safety and efficacy of oral baclofen in reducing muscle tone-related disability resulting from neurological damage or a stable neurological disorder and to evaluate drug-therapy tolerance.
Interventions
- DRUG intramuscular Botox versus oral baclofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2006-02 |
| Est. Completion | 2009-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00280280
The ClinicalTrials.gov registry entry for NCT00280280 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which intramuscular Botox versus oral baclofen is the first listed.
NCT00280280 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00280280 about?
NCT00280280 is a clinical study titled "Botox vs. Baclofen for Upper Limb Spasticity". The purposes of this pilot study are to evaluate the safety and efficacy of Botox® compared to the safety and efficacy of oral baclofen in reducing muscle tone-related disability resulting from neurological damage or a stable neurological disorder and to evaluate drug-therapy tolerance.
What is the current status of trial NCT00280280?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2006-02. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00280280?
The interventions under investigation include: intramuscular Botox versus oral baclofen (DRUG).
Who is sponsoring clinical trial NCT00280280?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.